Mobile intervention for preventing suicide in older adults
Official title: WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Run by Weill Medical College of Cornell University · NCT05183230 · Data updated 2026-11-12
This study tests a mobile program that helps older adults who have recently been hospitalized for suicidal thoughts or attempts learn to manage their emotions better and reduce their risk of suicide.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 90 Years |
| Sex | All |
| Enrollment | 115 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Status | Recruiting |
| Started | April 22, 2022 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT05183230 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 50-90 who have been hospitalized for suicidal ideation or attempts and meet specific DSM-5 diagnostic criteria.
✕Probably not a fit
Patients with current psychotic disorders, dementia, or significant cognitive impairment may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to evaluate the effectiveness of WellPATH-PREVENT, a mobile psychosocial intervention designed to enhance cognitive reappraisal abilities and reduce suicide risk among middle-aged and older adults who have recently been hospitalized for suicidal ideation or attempts. The intervention will be administered over 12 weeks, with participants receiving training on using a tablet to track triggers and emotions while being coached by interventionists. The study includes multiple assessments at key points, including hospital discharge and follow-ups at 6 and 12 weeks, to monitor progress and outcomes. An EEG will also be conducted to gather additional data on emotional regulation.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce suicide risk and improve emotional regulation in vulnerable older adults.
How similar studies have gone: Other studies have shown promise in using mobile interventions for mental health, but this specific approach is novel and untested in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50-90 years old * Diagnosis (based on a modified SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 except: current diagnosis of Psychotic Disorder; diagnosis of Dementia * Recent hospitalization for suicidal ideation or suicide attempt; at hospital admission, Columbia Suicide Severity Rating Scale (CSSR-S) ≥ 2, "Non-specific Active Suicidal Thoughts." * We will also include patients on psychotropics and on after-care community psychotherapy. Exclusion Criteria: * Current diagnosis of Psychotic Disorders; Diagnosis of Dementia * Cognitive Impairment (MMSE ≤ 24) * Acute or severe medical illness (i.e., delirium; decompensated cardiac, liver or kidney failure; major surgery; stroke or myocardial infarction during the three months prior to entry * Aphasia, sensory problems, and/or inability to speak English.
Where it's running
-
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine
White Plains, New York, United States Recruiting -
New York Presbyterian Hospital/Weill Cornell Medicine
New York, New York, United States Not yet recruiting
Study contacts
- Principal investigator: Dimitris Kiosses, PhD — Weill Medical College of Cornell University
- Study coordinator: Dimitris Kiosses, PhD
- Email: dkiosses@med.cornell.edu
- Phone: 914-997-4381
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Mindfulness-based programs for suicidal thoughts and self-harm in Korean youth
We will test whether two mindfulness-based programs for Korean adolescents and young adults reduce suicidal thoughts, self-harm, depression, and problems with sleep and emotion regulation.
-
Youth suicide risk factors and personalized reduction strategies in young adults
This study tests whether combining clinical data, genetic information, neuroimaging, and microbiome data can help identify risk factors and see if a dTMS-based intervention reduces suicide risk in young adults with mood disorders.
-
Long-term follow-up of depression in psychiatric care
This project will follow 415 people with difficult-to-treat depression who were previously studied to see how their symptoms and treatment outcomes change over five years.
-
SAFETY family-based program for youths after a suicide attempt
This project will test whether the SAFETY family-based therapy helps 10-17-year-olds who recently attempted suicide avoid repeat attempts.
-
Improving coping to reduce suicide risk after ED discharge
This study tests whether an electronic safety plan and supportive text messages can help adults who have recently had suicidal thoughts or behaviors after leaving the emergency department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.